Contact: Barbara Fornasiero, EAFocus,  Inc., 248.260.8466 or

ANN ARBOR, Mich.—May 23, 2018—For the fifth consecutive year, Managing Intellectual Property, publisher of the annual comprehensive legal directory IP STARS, has accorded a Highly Recommended ranking to the Illinois office of intellectual property law firm Brinks Gilson & Lione, one of the nation’s largest intellectual property law firms, and a Recommended ranking to the firm’s offices in Michigan and North Carolina.

The publication recognized Brinks Gilson & Lione in the areas of Copyright, Patent Contentious, Patent Prosecution, Trademark Contentious, and Trademark Prosecution.

Based on feedback from peers and clients, Managing IP additionally acknowledged ten Brinks attorneys as outstanding IP practitioners in its IP Stars list.

Steven L. Oberholtzer, managing shareholder of Brinks’ Ann Arbor office, was named a Patent Star and Trademark Star, as were Chicago-based attorneys James R. Sobieraj, William H. Frankel and Brad Lane, and Alejandro (Alex) Fernandez of the firm’s Tampa, Fla. office.

Managing IP recognized Ann Arbor shareholder Lawrence G. Almeda as a Patent Star, as well as Andrew D. Stover in Chicago, Allen R. Baum in Research Triangle Park, N.C., and Gregory Loyde Hillyer in Washington, D.C. Jeffery A. Handelman in Chicago was also recognized as a Trademark Star.

Managing IP annually ranks lawyers and law firms in over 80 jurisdictions following a six-month period consisting of surveys, interviews, and independent analyst research. More information is at

Brinks Gilson & Lione

Celebrating more than 100 years of intellectual property law, Brinks Gilson & Lione is one of the largest intellectual property law firms in the US, and helps clients around the world to protect and enforce their intellectual property rights. Our more than 130 lawyers, patent agents and scientific advisors assist clients in all aspects of patent, trademark, unfair competition, trade secret, and copyright law. Brinks attorneys provide informed counsel with respect to innovations in a range of complex and valuable technologies, including pharmaceuticals, chemicals, bioengineering, industrial manufacturing, electronics and software, and medical devices. More information is at